Insider Transactions in Q4 2023 at Jasper Therapeutics, Inc. (JSPR)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 28
2023
|
Thomas G Wiggans Director |
BUY
Open market or private purchase
|
Direct |
10,000
+16.67%
|
$0
$0.65 P/Share
|
|
Nov 21
2023
|
Thomas G Wiggans Director |
BUY
Open market or private purchase
|
Direct |
10,000
+20.0%
|
$0
$0.64 P/Share
|
|
Nov 20
2023
|
Thomas G Wiggans Director |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$0
$0.63 P/Share
|
|
Nov 17
2023
|
Thomas G Wiggans Director |
BUY
Open market or private purchase
|
Direct |
10,000
+33.33%
|
$0
$0.6 P/Share
|
|
Nov 16
2023
|
Thomas G Wiggans Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$0
$0.6 P/Share
|
|
Oct 13
2023
|
William Lis Director |
SELL
Open market or private sale
|
Direct |
7,965
-12.95%
|
$0
$0.85 P/Share
|
|
Oct 12
2023
|
Ron Martell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
87,531
-20.9%
|
$0
$0.85 P/Share
|
|
Oct 12
2023
|
Jeetinder Singh Mahal Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,126
-12.93%
|
$0
$0.85 P/Share
|